ANOVA LAML specific result package

Francesco Iorio, EMBL - European Bioinformatics Institute
result parsing started on 2016-03-31 12:30:59 iorio@ebi.ac.uk

Drug Domain: GDSC1000_paper_set, Analysis Domain: LAML specific


Individual drug analysis: 302


Drug details and screening numbers

Drug Name: PI-103
Drug ID: 302
Synonyms:
Brand name:
Target: PI3Ka, PRKDC (DNAPK)

Number of cell lines screened: 915
Screening concentration range(s): 0.04 to 10.24 uM


Statistically significant associations identified = 1

association id

FEATURE

Drug id

Propr

Public

Drug Name

Drug Target

N FEATURE pos

N FEATURE neg

log max Conc tested

FEATURE neg logIC50 MEAN

FEATURE pos logIC50 MEAN

FEATURE deltaMEAN IC50

FEATURE IC50 effectSize

FEATURE neg Glass delta

FEATURE pos Glass delta

ANOVA FEATURE pval

Tissue ANOVA pval

MSI ANOVA pval

ANOVA FEATURE FDR %

a14

NRAS_mut

302

1

1

PI-103

PI3Ka, PRKDC (DNAPK)

7

19

2.33

-2.24

0.595

2.84

1.9 *

2.1 **

1.5 *

3.98e-04

NA

1.65e-02

3.3

All-tests volcano plot